Filing metadata

Accession number
0001600620-24-000116
Form type
Form 4
Filer
Aurinia Pharmaceuticals Inc.
CIK
CIK 1600620
Filed
Nov 12, 2024
Reporting period
Nov 08, 2024
Description
Insider transaction

Explore SEC Filings Hub